Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Oct 8, 2015
Insider Transaction Report
Form 4
Kress Jean-Paul
Director
Transactions
- Award
Non-Qualified Stock Options (right to buy)
2015-09-29+7,692→ 7,692 totalExercise: $31.90Exp: 2025-09-29→ Common Stock (7,692 underlying)
Footnotes (1)
- [F1]This option will vest at a rate of 25% annually over four years on the earlier of (i) the anniversary date of the grant and (ii) the date of the annual meeting of our stockholders in the year following the date of grant.